BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18243528)

  • 1. Molecular mechanism of the inhibitory effect of KS-5 on bFGF-induced angiogenesis in vitro and in vivo.
    Peng CY; Pan SL; Lee KH; Bastow KF; Teng CM
    Cancer Lett; 2008 May; 263(1):114-21. PubMed ID: 18243528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moscatilin, a bibenzyl derivative from the India orchid Dendrobrium loddigesii, suppresses tumor angiogenesis and growth in vitro and in vivo.
    Tsai AC; Pan SL; Liao CH; Guh JH; Wang SW; Sun HL; Liu YN; Chen CC; Shen CC; Chang YL; Teng CM
    Cancer Lett; 2010 Jun; 292(2):163-70. PubMed ID: 20056528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-angiogenic activity of conjugated linoleic acid on basic fibroblast growth factor-induced angiogenesis.
    Moon EJ; Lee YM; Kim KW
    Oncol Rep; 2003; 10(3):617-21. PubMed ID: 12684633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-angiogenic function of tocotrienol.
    Miyazawa T; Shibata A; Nakagawa K; Tsuzuki T
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():253-6. PubMed ID: 18296349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of corneal angiogenesis by local application of vasostatin.
    Wu PC; Yang LC; Kuo HK; Huang CC; Tsai CL; Lin PR; Wu PC; Shin SJ; Tai MH
    Mol Vis; 2005 Jan; 11():28-35. PubMed ID: 15660022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of campesterol from Chrysanthemum coronarium L. and its antiangiogenic activities.
    Choi JM; Lee EO; Lee HJ; Kim KH; Ahn KS; Shim BS; Kim NI; Song MC; Baek NI; Kim SH
    Phytother Res; 2007 Oct; 21(10):954-9. PubMed ID: 17604370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
    Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
    Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-angiogenic activity of inositol hexaphosphate (IP6).
    Vucenik I; Passaniti A; Vitolo MI; Tantivejkul K; Eggleton P; Shamsuddin AM
    Carcinogenesis; 2004 Nov; 25(11):2115-23. PubMed ID: 15297368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of the Raf/MEK/ERK signaling cascade and inhibition of angiogenesis by the carboxyl terminus of angiopoietin-like protein 4.
    Yang YH; Wang Y; Lam KS; Yau MH; Cheng KK; Zhang J; Zhu W; Wu D; Xu A
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):835-40. PubMed ID: 18340008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activities of synthetic and natural stilbenes through antiangiogenic action.
    Kimura Y; Sumiyoshi M; Baba K
    Cancer Sci; 2008 Oct; 99(10):2083-96. PubMed ID: 19016770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
    Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis.
    Zhao H; Liu H; Chen Y; Xin X; Li J; Hou Y; Zhang Z; Zhang X; Xie C; Geng M; Ding J
    Cancer Res; 2006 Sep; 66(17):8779-87. PubMed ID: 16951194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.
    Chintalapati M; Truax R; Stout R; Portier R; Losso JN
    J Agric Food Chem; 2009 Jun; 57(12):5201-10. PubMed ID: 19476359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo inhibition of angiogenesis by a soluble form of melanotransferrin.
    Michaud-Levesque J; Demeule M; BĂ©liveau R
    Carcinogenesis; 2007 Feb; 28(2):280-8. PubMed ID: 16857721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-angiogenic effect of the seed extract of Benincasa hispida Cogniaux.
    Lee KH; Choi HR; Kim CH
    J Ethnopharmacol; 2005 Mar; 97(3):509-13. PubMed ID: 15740888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase.
    Uruno A; Sugawara A; Kudo M; Satoh F; Saito A; Ito S
    Hypertens Res; 2008 Nov; 31(11):2085-96. PubMed ID: 19098381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic activity of bFGF and VEGF suppressed by proteolytic cleavage by neutrophil elastase.
    Ai S; Cheng XW; Inoue A; Nakamura K; Okumura K; Iguchi A; Murohara T; Kuzuya M
    Biochem Biophys Res Commun; 2007 Dec; 364(2):395-401. PubMed ID: 17950695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis.
    Kou B; Ni J; Vatish M; Singer DR
    Microcirculation; 2008 Apr; 15(3):251-67. PubMed ID: 18386220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPOX inhibits angiogenesis by degradation of Mcl-1 through ERK inactivation.
    Sun HL; Tsai AC; Pan SL; Ding Q; Yamaguchi H; Lin CN; Hung MC; Teng CM
    Clin Cancer Res; 2009 Aug; 15(15):4904-14. PubMed ID: 19622586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.